Search
Search Results
##search.searchResults.foundPlural##
-
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3494PDF: 1991HTML: 3746 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4745PDF: 1608HTML: 8566 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
315PDF: 809HTML: 82 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1956PDF: 587HTML: 377 -
FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients
1168PDF: 694Html: 189 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1795PDF: 834HTML: 1526 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4879PDF: 2108HTML: 18246 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1787PDF: 913HTML: 1296Figure 1: 228Figure 2: 238Figure 3: 243 -
-
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1318PDF: 1216HTML: 535 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
5425PDF: 2103HTML: 11596Fig 1: 314Fig 2: 252Fig 3: 373Fig 4: 278Fig 5: 263Fig 6: 246Fig 7: 276Fig 8: 250 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1928PDF: 1028HTML: 1212Untitled: 225Untitled: 236Untitled: 235Untitled: 220 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
3171PDF: 1240HTML: 4725 -
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
691PDF: 679Suppl. Files: 99HTML: 180 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1929PDF: 642HTML: 17009Figure 4: 239Figure 3: 205Figure 2: 202Figure 1: 231 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4760Suppl. Files: 1296PDF: 1195Html: 349 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3792PDF: 1335HTML: 537 -
WHAT ARE FUNGAL INFECTIONS?
4475PDF: 2556HTML: 27723de Pauw: 312 -
-
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1782PDF: 721HTML: 2459 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1134PDF: 588HTML: 761 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5260PDF: 3046HTML: 2389 -
-
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2755PDF: 1309HTML: 1129







